MYC and prostate cancer: Further, we recently showed that “receptor-positive” breast and prostate cancer cells (MCF-7 and C4-2B cells respectively) have faster rates of fatty acid oxidation than “receptor-negative” cells (MDA-MB-231 and PC-3 cells) [3, 4], whereas others have reported that triple-negative breast cancer cells with high MYC expressed have faster rates of fatty acid oxidation compared to low MYC expressing triple-negative breast cancer cells and receptor-positive cells (T47D) [277].